{"id":"https://openalex.org/W2116927299","doi":"https://doi.org/10.1002/bdd.2510060207","title":"Concentration\u2010dependent clearance of procainamide in normal subjects","display_name":"Concentration\u2010dependent clearance of procainamide in normal subjects","publication_year":1985,"publication_date":"1985-04-01","ids":{"openalex":"https://openalex.org/W2116927299","doi":"https://doi.org/10.1002/bdd.2510060207","mag":"2116927299","pmid":"https://pubmed.ncbi.nlm.nih.gov/2408690"},"language":"en","primary_location":{"id":"doi:10.1002/bdd.2510060207","doi":"https://doi.org/10.1002/bdd.2510060207","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510060207","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"James D. Coyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Coyle","raw_affiliation_strings":["Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005862923","display_name":"Harisios K Boudoulas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harisios Boudoulas","raw_affiliation_strings":["Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015972118","display_name":"Janis J. MacKichan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janis J. Mackichan","raw_affiliation_strings":["Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108423726","display_name":"John J. Lima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John J. Lima","raw_affiliation_strings":["Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Pharmacy Practice and Cardiology, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH, U.S.A","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.4083,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.60726,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"6","issue":"2","first_page":"159","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/procainamide","display_name":"procainamide","score":1.0},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.7599999904632568},{"id":"https://openalex.org/keywords/nonrenal-clearance","display_name":"nonrenal clearance","score":0.828000009059906},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9139999747276306},{"id":"https://openalex.org/keywords/therapeutic-plasma-concentration","display_name":"therapeutic plasma concentration","score":0.5920000076293945},{"id":"https://openalex.org/keywords/elimination-rate-constant","display_name":"elimination rate constant","score":0.8360000252723694},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.3330000042915344}],"concepts":[{"id":"https://openalex.org/C2777028498","wikidata":"https://www.wikidata.org/wiki/Q417597","display_name":"Procainamide","level":2,"score":0.921139121055603},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5263066291809082},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5158900022506714},{"id":"https://openalex.org/C2909957684","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Metabolic clearance rate","level":3,"score":0.4338390529155731},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4117122292518616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39381682872772217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3395957350730896}],"mesh":[{"descriptor_ui":"D000120","descriptor_name":"Acecainide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011342","descriptor_name":"Procainamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011342","descriptor_name":"Procainamide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011342","descriptor_name":"Procainamide","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/bdd.2510060207","doi":"https://doi.org/10.1002/bdd.2510060207","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510060207","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},{"id":"pmid:2408690","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2408690","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2124107224","display_name":null,"funder_award_id":"RR 34","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W10132982","https://openalex.org/W619697323","https://openalex.org/W1937334656","https://openalex.org/W2030264697","https://openalex.org/W2033906759","https://openalex.org/W2039435594","https://openalex.org/W2054299265","https://openalex.org/W2074900741","https://openalex.org/W2086248198","https://openalex.org/W2090562696","https://openalex.org/W2155069195","https://openalex.org/W2414995470","https://openalex.org/W2502670554","https://openalex.org/W2603572041"],"related_works":["https://openalex.org/W2414995470","https://openalex.org/W2402406793","https://openalex.org/W1988859967","https://openalex.org/W2155853126","https://openalex.org/W2441946570","https://openalex.org/W2064019628","https://openalex.org/W2055985921","https://openalex.org/W2198140643","https://openalex.org/W1975036071","https://openalex.org/W2438634853"],"abstract_inverted_index":{"Four":[0],"normal":[1,191],"volunteers":[2],"each":[3,50],"received":[4],"two":[5],"intravenous":[6],"doses":[7,89,162],"of":[8,171,186,206],"PA.":[9],"The":[10,63,77],"mean":[11,24,78],"low":[12,86,121],"dose":[13,26],"was":[14,27,44],"3.30":[15],"mg":[16,29],"kg-1":[17,30],"(infused":[18,31],"over":[19,32],"20":[20],"minutes)":[21],"while":[22,108],"the":[23,71,85,120,143,181,201],"high":[25,88,123],"12.5":[28],"60":[33],"minutes).":[34],"Blood":[35],"samples":[36],"were":[37,54,90,173],"collected":[38,45],"for":[39,46],"12":[40],"hours":[41,48],"and":[42,59,66,87,92,104,115,122,169,183,198],"urine":[43],"48":[47],"after":[49,119],"dose.":[51],"PA":[52,81,98,130,187,196],"concentrations":[53,65,82,197],"determined":[55],"by":[56],"both":[57],"HPLC":[58,72],"fluorescent":[60],"immunoassay":[61],"methods.":[62],"reported":[64],"pharmacokinetic":[67],"parameters":[68],"are":[69,188,205],"from":[70,84,133,150],"data":[73],"unless":[74],"otherwise":[75],"indicated.":[76],"peak":[79],"serum":[80],"resulting":[83],"3.18":[91],"9.07":[93],"micrograms":[94],"ml-1,":[95],"respectively.":[96,125],"Total":[97,146],"clearance":[99,110,131,147,203],"averaged":[100,111],"763":[101],"ml":[102,106,113,117],"min-1":[103,107,114,118],"577":[105],"renal":[109,164],"360":[112],"318":[116],"doses,":[124],"Concentration-dependent":[126],"decreases":[127,148],"in":[128,142,163,190],"nonrenal":[129,182],"ranged":[132,149],"31":[134],"to":[135,152,209],"43":[136],"percent":[137],"(p":[138,156],"less":[139,157],"than":[140,158],"0.05)":[141],"four":[144],"subjects.":[145],"4.7":[151],"36":[153],"per":[154],"cent":[155],"0.05).":[159],"Differences":[160],"between":[161],"clearance,":[165],"elimination":[166],"rate":[167],"constant,":[168],"volume":[170],"distribution":[172],"not":[174],"statistically":[175],"significant.":[176],"This":[177],"study":[178],"demonstrates":[179],"that":[180,200],"total":[184,202],"clearances":[185],"concentration-dependent":[189],"subjects":[192],"at":[193],"therapeutic":[194],"plasma":[195],"suggests":[199],"changes":[204],"sufficient":[207],"magnitude":[208],"be":[210],"clinically":[211],"important.":[212]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}